Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexandra Calmy

Showing results (361-370 of 415) with videos related to

Pageof 42
Sort By:
AIDS (London, England)|August 23, 2018
Aging and the evolution of comorbidities among HIV-positive individuals in a European cohortAnnegret Pelchen-Matthews, Lene Ryom, Álvaro H Borges, et al.
BMJ Open|November 13, 2020
Efficacy of pragmatic same-day ring prophylaxis for adult individuals exposed to SARS-CoV-2 in Switzerland (COPEP): protocol of an open-label cluster randomised trialMikaela Smit, Annalisa Marinosci, Giovanni Jacopo Nicoletti, et al.
Open Forum Infectious Diseases|September 23, 2022
Anticholinergic and Sedative Medications Are Associated With Neurocognitive Performance of Well Treated People With Human Immunodeficiency VirusBernadette Jakeman, Alexandra U Scherrer, Katharine E A Darling, et al.
Plos One|March 2, 2021
Alcohol consumption and neurocognitive deficits in people with well-treated HIV in SwitzerlandKatharine E A Darling, Isabella Locatelli, Nadia Benghalem, et al.
AIDS (London, England)|July 18, 2022
Changes in body mass index and clinical outcomes after initiation of contemporary antiretroviral regimensWendy P Bannister, T Christopher Mast, Stéphane de Wit, et al.
Open Forum Infectious Diseases|December 14, 2019
Corrigendum to: Impact of the M184V/I Mutation on the Efficacy of Abacavir/Lamivudine/Dolutegravir Therapy in HIV Treatment-Experienced PatientsFlaminia Olearo, Huyen Nguyen, Fabrice Bonnet, et al.
The Journal of Infectious Diseases|July 13, 2013
Origin of minority drug-resistant HIV-1 variants in primary HIV-1 infectionKarin J Metzner, Alexandra U Scherrer, Benjamin Preiswerk, et al.
Open Forum Infectious Diseases|October 30, 2019
Impact of the M184V/I Mutation on the Efficacy of Abacavir/Lamivudine/Dolutegravir Therapy in HIV Treatment-Experienced PatientsFlaminia Olearo, Huyen Nguyen, Fabrice Bonnet, et al.
Virologie (Montrouge, France)|March 10, 2023
MOSAIC: a European cohort study of human Mpox - the challenges of clinical research in outbreaksSabrina Kali, Josephine Bourner, Alexandra Calmy, et al.
The Journal of Infectious Diseases|March 6, 2019
Viral Diversity Based on Next-Generation Sequencing of HIV-1 Provides Precise Estimates of Infection Recency and Time Since InfectionLouisa A Carlisle, Teja Turk, Katharina Kusejko, et al.
Pageof 42

Showing results (361-370 of 415) with videos related to

Sort By:
Pageof 42
AIDS (London, England)|August 23, 2018
Aging and the evolution of comorbidities among HIV-positive individuals in a European cohortAnnegret Pelchen-Matthews, Lene Ryom, Álvaro H Borges, et al.
BMJ Open|November 13, 2020
Efficacy of pragmatic same-day ring prophylaxis for adult individuals exposed to SARS-CoV-2 in Switzerland (COPEP): protocol of an open-label cluster randomised trialMikaela Smit, Annalisa Marinosci, Giovanni Jacopo Nicoletti, et al.
Open Forum Infectious Diseases|September 23, 2022
Anticholinergic and Sedative Medications Are Associated With Neurocognitive Performance of Well Treated People With Human Immunodeficiency VirusBernadette Jakeman, Alexandra U Scherrer, Katharine E A Darling, et al.
Plos One|March 2, 2021
Alcohol consumption and neurocognitive deficits in people with well-treated HIV in SwitzerlandKatharine E A Darling, Isabella Locatelli, Nadia Benghalem, et al.
AIDS (London, England)|July 18, 2022
Changes in body mass index and clinical outcomes after initiation of contemporary antiretroviral regimensWendy P Bannister, T Christopher Mast, Stéphane de Wit, et al.
Open Forum Infectious Diseases|December 14, 2019
Corrigendum to: Impact of the M184V/I Mutation on the Efficacy of Abacavir/Lamivudine/Dolutegravir Therapy in HIV Treatment-Experienced PatientsFlaminia Olearo, Huyen Nguyen, Fabrice Bonnet, et al.
The Journal of Infectious Diseases|July 13, 2013
Origin of minority drug-resistant HIV-1 variants in primary HIV-1 infectionKarin J Metzner, Alexandra U Scherrer, Benjamin Preiswerk, et al.
Open Forum Infectious Diseases|October 30, 2019
Impact of the M184V/I Mutation on the Efficacy of Abacavir/Lamivudine/Dolutegravir Therapy in HIV Treatment-Experienced PatientsFlaminia Olearo, Huyen Nguyen, Fabrice Bonnet, et al.
Virologie (Montrouge, France)|March 10, 2023
MOSAIC: a European cohort study of human Mpox - the challenges of clinical research in outbreaksSabrina Kali, Josephine Bourner, Alexandra Calmy, et al.
The Journal of Infectious Diseases|March 6, 2019
Viral Diversity Based on Next-Generation Sequencing of HIV-1 Provides Precise Estimates of Infection Recency and Time Since InfectionLouisa A Carlisle, Teja Turk, Katharina Kusejko, et al.
Pageof 42